FDA Accepts BioCardia Helix Catheter De Novo Pre-Submission
The FDA accepted BioCardia’s De Novo pre-submission for marketing clearance of its Helix catheter. Substantive review and an FDA meeting are expected this quarter.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.